Authors:
Goldstein, DR
Thomas, JM
Kirklin, JK
George, JF
Citation: Dr. Goldstein et al., Indefinite allograft survival mediated by donor bone marrow is dependent on the presence of a functional CD95 (Fas) gene in recipients, J HEART LUN, 20(10), 2001, pp. 1132-1135
Authors:
Goldstein, DR
Thomas, JM
Kirklin, JK
George, JF
Citation: Dr. Goldstein et al., An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells, TRANSPLANT, 72(5), 2001, pp. 954-956
Authors:
McCoy, KL
Goldstein, DR
Gahtan, V
Mayro, G
Kerstein, MD
Citation: Kl. Mccoy et al., Peripheral vascular disease intervention in patients with end-stage renal disease: Few complications in those treated with peritoneal dialysis, SOUTH MED J, 94(10), 2001, pp. 1002-1005
Authors:
Goldstein, DR
Chang, T
Sweeney, SD
Kirklin, JK
Thomas, JM
George, JF
Citation: Dr. Goldstein et al., A differential requirement for CD8(+) donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells, TRANSPLANT, 70(7), 2000, pp. 1068-1073
Authors:
Goldstein, DR
Chang, T
Sweeney, SD
Kirklin, JK
Thomas, JM
George, JF
Citation: Dr. Goldstein et al., Enhanced allograft survival induced by posttransplant donor spleen cell infusion occurs via a mechanism that is distinct from the mechanism of enhancement by donor bone marrow, TRANSPLANT, 69(5), 2000, pp. 1020-1022
Citation: Jf. George et al., Donor bone marrow and transplantation tolerance: Historical perspectives, molecular mechanisms and future directions (Review), INT J MOL M, 4(5), 1999, pp. 475-482